Skip to content
Prevest Denpro logo

Prevest Denpro

543363 BSE
Price unavailable

Prevest Denpro (PREVEST) share price was ₹379.65 at the 28 Oct 2026 close; market capitalisation ₹456 Cr; P/E (TTM) 20.19; sector Healthcare. The share price fell 29.0% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 23.7% year on year to ₹19.44 Cr and net profit rose 24.8% year on year to ₹5.78 Cr (compared with Jun 2025). Promoters held 73.60% of Prevest Denpro in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 59/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹379.65 −141.45 −27.14% 1Y

Key Fundamentals

SMEHealthcare Equipment & SuppliesHealthcare
Market Cap
₹456 Cr
P/E (TTM)
20.19
EBITDA
₹29.60 Cr
Return on Equity
16.42%
Debt to Equity
0
Book Value
₹103.97
EPS (TTM)
₹18.80
52W High
₹546.00
52W Low
₹318.15

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Medical Equipment › Medical Equipment & Supplies

₹1,463.3047.0714,832 Cr4.780.24%10.18%13.33%2,115 Cr313 Cr
₹26.2669.111,719 Cr3.760.20%8.11%12.69%373 Cr24 Cr
₹307.95147.341,638 Cr2.580.66%2.26%4.82%468 Cr11 Cr
₹550.0026.071,283 Cr2.630.00%22.63%26.37%201 Cr34 Cr
₹178.4031.80982 Cr4.030.00%10.83%11.51%289 Cr31 Cr
——832 Cr5.310.00%13.22%19.52%——
Prevest Denpro (this company)
—20.19456 Cr3.650.26%16.42%21.91%80 Cr23 Cr
Median 7 companies₹307.9539.441,283 Cr3.760.20%10.83%13.33%331 Cr28 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

59 Good
Overall score

Data confidence 98/100

Category scores

Quality Strong 81
Returns, margins, earnings quality 22% weight
Valuation Average 47
Cheap vs sector & own history 24% weight
Growth Good 59
Sales & profit trajectory 9% weight
Financial Health Strong 86
Solvency, leverage, coverage 9% weight
Momentum Weak 38
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
12
Neutral
4
Bullish
3

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
14.31% higher than 3Y

change over 1 year

Net Income Growth
12.64% higher than 3Y

change over 1 year

Cash Flow Change
-0.07%

change over 1 year

EBITDA Margin Change
-0.9%

change over 1 year Operating margin 35.44% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
13.39
13.18
13.62
16.24
13.34
16.26
14.93
18.54
15.72
18.66
18.37
18.9
19.44
Expenses
8.43
8.68
9.15
10.36
8.85
10.45
9.79
11.91
10.19
11.96
12.15
11.81
12.55
Operating Profit
4.96
4.5
4.47
5.88
4.49
5.81
5.14
6.63
5.53
6.7
6.22
7.09
6.89
OPM %
37.04%
34.14%
32.82%
36.21%
33.66%
35.73%
34.43%
35.76%
35.18%
35.91%
33.86%
37.51%
35.44%
Other Income
0.61
0.74
0.68
0.84
0.86
1.07
1.1
1.08
1.17
1.2
1.16
1.46
1.33
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.17
0.22
0.42
0.46
0.48
0.47
0.48
0.47
0.49
0.5
0.51
0.5
0.52
PBT
5.4
5.02
4.73
6.26
4.87
6.41
5.76
7.24
6.21
7.4
6.87
8.05
7.7
Tax %
24.26%
25.7%
23.26%
25.56%
25.26%
24.49%
22.4%
27.49%
25.44%
24.73%
25.04%
24.72%
24.94%
Net Profit
4.08
3.74
3.64
4.66
3.65
4.84
4.46
5.25
4.63
5.57
5.15
6.06
5.78
EPS (₹)
3.4
3.12
3.03
3.88
3.04
4.03
3.72
4.37
3.86
4.64
4.29
5.05
4.82
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
19
23
28
38
50
56
63
72
75
Expenses
15
17
19
23
30
36
41
46
48
Operating Profit
4
5
9
15
20
20
22
26
27
OPM %
20%
23%
32%
40%
40%
36%
35%
36%
36%
Other Income
0
2
1
2
2
3
4
5
5
Interest
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
1
1
1
2
2
2
PBT
4
6
9
16
21
21
24
29
30
Tax %
20%
20%
23%
28%
25%
25%
25%
25%
—
Net Profit
3
5
7
12
16
16
18
21
23
EPS (₹)
3.22
5.39
8.19
9.64
13.09
13.43
15.16
17.85
18.8
Div. Payout %
0%
0%
0%
0%
8%
7%
7%
6%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.29
0.29
0.29
12
12
12
12
12
Reserves
10
15
22
45
61
77
94
114
Borrowings
1
2
1
1
0
0
0
0
Other Liabilities
4
4
7
6
6
6
7
8
Total Liabilities
15
21
31
64
79
95
113
134
Fixed Assets
5
5
5
7
7
27
27
27
CWIP
0
0
2
5
17
0
0
0
Investments
0
0
0
1
1
2
5
9
Other Assets
10
16
23
52
53
66
81
98
Total Assets
15
21
31
64
79
95
113
134
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
3
5
9
7
10
11
15
16
Investing
-1
-1
-2
-4
-12
-2
-2
-2
Financing
0
0
-1
23
-1
0
-1
-1
Net Cash Flow
2
4
6
26
-3
9
12
12
Free Cash Flow
2
4
7
2
-3
8
13
14
CFO/EBITDA
96
115
118
75
79
80
94
87
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
46
35
48
22
31
53
45
45
Inventory Days
28
59
59
122
139
162
208
235
Days Payable
70
72
181
61
40
34
42
54
Cash Conversion Cycle
4
22
-74
83
130
181
211
227
Working Capital Days
10
20
3
41
64
80
81
89
ROCE %
—
45%
47%
40%
32%
27%
25%
25%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Prevest Denpro insights

59 extracted metrics + investor summaries across FY19–FY27.

Shareholding Pattern

FIIs0.65%Promot.73.60%DIIs0.79%Others8.05%Public16.90%As ofSep 2026

Documents

Frequently Asked Questions about Prevest Denpro

What does Prevest Denpro Ltd do?
Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.
Where is Prevest Denpro Ltd (PREVEST) listed?
Prevest Denpro Ltd trades under code 543363 on the BSE.
Which sector does Prevest Denpro Ltd belong to?
Prevest Denpro Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Prevest Denpro Ltd?
Prevest Denpro Ltd has a market capitalisation of ₹455.72 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Prevest Denpro Ltd?
Prevest Denpro Ltd trades at a PE ratio of 20.19 as of 28 Oct 2026, on earnings per share of ₹18.8, against a book value of ₹103.97 per share.
What is the 52-week high and low of Prevest Denpro Ltd?
Over the last 52 weeks Prevest Denpro Ltd has traded between ₹318.15 and ₹546 as of 28 Oct 2026.
Does Prevest Denpro Ltd pay dividends?
Prevest Denpro Ltd has a dividend yield of 0.26%.
What is the Return on Equity (ROE) of Prevest Denpro Ltd?
Prevest Denpro Ltd reported a return on equity of 16.42%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.

Listed 2021-09-27
Face Value ₹ 10
Shares Outstanding 1,20,03,564

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543363.md for Prevest Denpro Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More